DiaMedica Therapeutics (DMAC) Free Cash Flow: 2017-2024
Historic Free Cash Flow for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to -$22.1 million.
- DiaMedica Therapeutics' Free Cash Flow rose 0.42% to -$1.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$9.1 million, marking a year-over-year decrease of 58.65%. This contributed to the annual value of -$22.1 million for FY2024, which is 17.99% down from last year.
- DiaMedica Therapeutics' Free Cash Flow amounted to -$22.1 million in FY2024, which was down 17.99% from -$18.8 million recorded in FY2023.
- In the past 5 years, DiaMedica Therapeutics' Free Cash Flow registered a high of -$9.2 million during FY2020, and its lowest value of -$22.1 million during FY2024.
- Over the past 3 years, DiaMedica Therapeutics' median Free Cash Flow value was -$18.8 million (recorded in 2023), while the average stood at -$17.5 million.
- Per our database at Business Quant, DiaMedica Therapeutics' Free Cash Flow grew by 5.56% in 2022 and then plummeted by 61.77% in 2023.
- DiaMedica Therapeutics' Free Cash Flow (Yearly) stood at -$9.2 million in 2020, then plummeted by 32.95% to -$12.3 million in 2021, then climbed by 5.56% to -$11.6 million in 2022, then plummeted by 61.77% to -$18.8 million in 2023, then declined by 17.99% to -$22.1 million in 2024.